Prediction and Conservancy Analysis of Multiepitope Based PeptideVaccine Against Merkel Cell Polyomavirus: An ImmunoinformaticsApproach

Mawadda Abd-Elraheem Awad-Elkareem, Soada A. Osman, H. Mohamed, H. Hassan, Ahmed Hamdi Abu-haraz, K. A. Abd-elrahman, M. Salih
{"title":"Prediction and Conservancy Analysis of Multiepitope Based PeptideVaccine Against Merkel Cell Polyomavirus: An ImmunoinformaticsApproach","authors":"Mawadda Abd-Elraheem Awad-Elkareem, Soada A. Osman, H. Mohamed, H. Hassan, Ahmed Hamdi Abu-haraz, K. A. Abd-elrahman, M. Salih","doi":"10.4172/1745-7580.1000134","DOIUrl":null,"url":null,"abstract":"Merkel cell Polyomavirus is non-enveloped, dsDNA virus belonging to Polyomaviridae family linked to an \n uncommon aggressive skin malignancy. The poor prognosis and limited understanding of disease pathogenesis \n warrants innovative treatment. In this current study we aim to predict TB cell immunogenic epitopes from the \n VP1 protein of all merkel cell polyomavirus strain which will aid in effective epitope based vaccine design using \n immuoinformatics approaches. We retrieved 423 full-length VP1 protein sequences of merkel cell polyomaviruse \n virus species from the NCBI database. These sequences were analyzed to determine the conserved region and were \n used to predict the epitopes using the IEDB immunoinformatics algorithms. For B cell three epitope were predicted \n as peptide vaccine (QEKTVY, KTVYPK, and QEKTVYP). For T cell the predicted Class-I peptides (SLFSNLMPK, \n LQMWEAISV and LLVKGGVEV) were found to cover the maximum number of MHC I alleles. The highest scoring \n Class II MHC binding peptides were (IELYLNPRM, ISSLINVHY and INSLFSNLM). Further experiments will need \n to be undertaken to confirm the potential of these predicted epitopes in a future efficacious vaccine development.","PeriodicalId":73347,"journal":{"name":"Immunome research","volume":"13 1","pages":"1-16"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunome research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/1745-7580.1000134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Merkel cell Polyomavirus is non-enveloped, dsDNA virus belonging to Polyomaviridae family linked to an uncommon aggressive skin malignancy. The poor prognosis and limited understanding of disease pathogenesis warrants innovative treatment. In this current study we aim to predict TB cell immunogenic epitopes from the VP1 protein of all merkel cell polyomavirus strain which will aid in effective epitope based vaccine design using immuoinformatics approaches. We retrieved 423 full-length VP1 protein sequences of merkel cell polyomaviruse virus species from the NCBI database. These sequences were analyzed to determine the conserved region and were used to predict the epitopes using the IEDB immunoinformatics algorithms. For B cell three epitope were predicted as peptide vaccine (QEKTVY, KTVYPK, and QEKTVYP). For T cell the predicted Class-I peptides (SLFSNLMPK, LQMWEAISV and LLVKGGVEV) were found to cover the maximum number of MHC I alleles. The highest scoring Class II MHC binding peptides were (IELYLNPRM, ISSLINVHY and INSLFSNLM). Further experiments will need to be undertaken to confirm the potential of these predicted epitopes in a future efficacious vaccine development.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Merkel细胞多瘤病毒多表位肽疫苗的免疫信息学预测及保护性分析
Merkel细胞多瘤病毒是一种非包膜dsDNA病毒,属于多瘤病毒科,与一种罕见的侵袭性皮肤恶性肿瘤有关。预后差,对疾病发病机制的了解有限,需要创新治疗。在本研究中,我们的目的是从所有merkel细胞多瘤病毒株的VP1蛋白中预测TB细胞免疫原性表位,这将有助于使用免疫信息学方法设计有效的基于表位的疫苗。我们从NCBI数据库中检索了423个默克细胞多瘤病毒VP1全长蛋白序列。分析这些序列以确定保守区,并使用IEDB免疫信息学算法预测表位。对于B细胞,预测了三个表位作为肽疫苗(QEKTVY、KTVYPK和QEKTVYP)。对于T细胞,发现预测的I类肽(SLFSNLMPK、LQMWEAISV和LLVKGGVEV)覆盖了最大数量的MHC I等位基因。得分最高的II类MHC结合肽是(IELYLNPRM、ISSLINVHY和INSLFSNLM)。需要进行进一步的实验来确认这些预测的表位在未来有效疫苗开发中的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mirage of Waning Immunity against SARS CoV-2 The Downside of Beauty: ASIA Syndrome Associated with Local Silicone Injections: A Literature Review Vaccines and Optic Neuritis: Consequence or Coincidence? MicroRNAs skin disorders The Best IgG Subclass for the Development of Therapeutic Monoclonal Antibody Drugs and their Commercial Production: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1